-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIGHT MINDS BIOSCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2 CLINICAL TRIAL OF BMB-101 IN PATIENTS WITH ABSENCE SEIZURES AND DEVELOPMENTAL AND ENCEPHALOPATHIC EPILEPSIES (DEE)

路透·01/06/2026 12:16:55

登錄查看新聞詳情